Pryor K D, Leiting B
Department of Biochemistry, Merck Research Laboratories, Rahway, New Jersey 07065, USA.
Protein Expr Purif. 1997 Aug;10(3):309-19. doi: 10.1006/prep.1997.0759.
Using the maltose-binding protein (MBP) fusion vector pMAL-c1 from C. V. Maina et al. (1988, Gene 74, 365-373), we have constructed expression vectors which contain a sequence encoding six consecutive histidine residues (His6-tag) at the 3' end of the MBP-encoding malE gene which is followed by either a thrombin-binding site (LVPRGS) or a factor Xa-binding site (IEGR). The benefits of this approach include; (a) high expression levels of soluble MBP fusion proteins (exceeding 2% of the total cellular protein), (b) high-quality purification of proteins under various conditions (high salt, low salt, denaturing, nondenaturing, etc.), and (c) two alternative protease cleavage sites to test for the most efficient cleavage of each fusion protein. We also constructed these MBP-His 6-tag expression vectors with alternative selection markers (Ampr, Kanr) and alternative promoters (tac, T7). Using these constructs, we expressed and purified several proteins of which we present two, penicillin-binding protein PBP2a and UDP-N-acetylmuramate:L-alanine ligase (MurC), and compare their expression level and purity with other expression systems. We also discuss the use of minimal media with supplements versus rich media and cell growth strategies to optimize the protein yield in general and for isotope labeling.
利用C. V. Maina等人(1988年,《基因》74卷,365 - 373页)构建的麦芽糖结合蛋白(MBP)融合载体pMAL-c1,我们构建了表达载体,这些载体在编码MBP的malE基因的3'端含有一个编码六个连续组氨酸残基(His6标签)的序列,该序列后面接着一个凝血酶结合位点(LVPRGS)或一个因子Xa结合位点(IEGR)。这种方法的优点包括:(a)可溶性MBP融合蛋白的高表达水平(超过细胞总蛋白的2%),(b)在各种条件下(高盐、低盐、变性、非变性等)对蛋白质进行高质量纯化,以及(c)两个可供选择的蛋白酶切割位点,用于测试每种融合蛋白的最有效切割。我们还构建了带有替代选择标记(Ampr、Kanr)和替代启动子(tac、T7)的这些MBP-His6标签表达载体。利用这些构建体,我们表达并纯化了几种蛋白质,这里展示其中两种,青霉素结合蛋白PBP2a和UDP-N-乙酰胞壁酸:L-丙氨酸连接酶(MurC),并将它们的表达水平和纯度与其他表达系统进行比较。我们还讨论了使用添加补充剂的基本培养基与丰富培养基以及细胞生长策略,以总体上优化蛋白质产量以及用于同位素标记。